We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
95 hedge funds and large institutions have $168M invested in Amphastar Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 42 increasing their positions, 22 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
91% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 22
0% more funds holding
Funds holding: 95 → 95 (0)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
21% less capital invested
Capital invested by funds: $213M → $168M (-$44.3M)
Holders
95
Holders Change
–
Holders Change %
0%
% of All Funds
2.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
42
Reduced
22
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.55M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.23M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.99M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.61M |
| 5 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
+$1.29M |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$14.6M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$2.2M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$2.16M |
| 4 |
JP Morgan Chase
New York
|
-$1.68M |
| 5 |
JG
Jefferies Group
New York
|
-$1.48M |
